Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care.

Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care. Ann Surg Oncol. 2022 09; 29(9):5344-5346.

View in: PubMed

subject areas

Carcinoma, Non-Small-Cell Lung
Humans
Immunotherapy
Lung Neoplasms
Neoadjuvant Therapy
Neoplasm Staging

authors with profiles

Jessica Donington